Navigation Links
Omeros' Ophthalmology Product OMS302 Successful in Second Phase 3 Clinical Trial
Date:11/5/2012

SEATTLE, Nov. 5, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today reported positive data from the second of its two pivotal Phase 3 clinical trials evaluating OMS302 in patients undergoing intraocular lens replacement surgery.  In this second Phase 3 clinical trial comparing OMS302 to placebo, OMS302 met its co-primary endpoints by demonstrating statistically significant (p<0.00001) maintenance of intraoperative mydriasis (pupil dilation) and statistically significant (p=0.0002) reduction of pain in the early postoperative period. OMS302, added to standard irrigation solution used during ophthalmological procedures, is Omeros' proprietary PharmacoSurgery™ product designed to maintain intraoperative mydriasis and reduce postoperative pain and irritation resulting from cataract and other lens replacement surgery. Now with positive data from both trials in the OMS302 Phase 3 clinical program, Omeros plans to submit a New Drug Application (NDA) with the U.S. Food and Drug Administration in the first half of 2013 and a Marketing Authorization Application (MAA) with the European Medicines Agency in mid-2013, potentially allowing sales in 2014.

This multicenter, double-blind, Phase 3 clinical trial enrolled 416 patients randomized 1:1 to receive either OMS302 or placebo. The co-primary endpoints were maintenance of intraoperative mydriasis (pupil dilation) and reduction of pain in the early postoperative period.  Mydriasis is critical to the safety and surgical ease of lens replacement surgery as intraoperative pupil constriction increases the risk of injury to intraocular structures and can substantially prolong surgical time.  OMS302 also achieved statistical significance in other clinically relevant measures. The results from this trial are consistent with those from Omeros' first OMS302 Phase 3 and earlier Phase 2b clinical trials.

'/>"/>
SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... PORTLAND, Ore. , July 25, 2014 /PRNewswire/ ... "Semler"), an emerging medical risk assessment company that ... monitoring patients and evaluating chronic diseases, today reported ... months ended June 30, 2014. ... productive for Semler," said Doug Murphy-Chutorian , ...
(Date:7/25/2014)... /PRNewswire-iReach/ -- Dr. Michael Gabriel of a prominent ... a recent study, which shows how grief in pregnancy may ... According to US News , ... likely than others to grow up overweight or obese, even ... were two specific types of stress that caused obesity: "Children ...
(Date:7/24/2014)... MADISON, Wis. , July 24, 2014 /PRNewswire/ ... provides specialty and compounded pharmaceuticals, announced that it ... sensitivity information unique to each individual based upon ... now possible by understanding the interaction between a ... "We,re very excited to provide this ...
Breaking Medicine Technology:Semler Reports Second Quarter 2014 Financial Results 2Semler Reports Second Quarter 2014 Financial Results 3Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3
... 10 Bayer HealthCare announced today the recipients ... Nursing Fellowship (IHNF).  This global initiative, supported by Bayer, ... countries – areas where hemophilia-trained healthcare professionals are in ... countries ( Algeria , Brazil , Cameroon ...
... July 9 Pioneer Surgical Technology, Inc. recently expanded its Biologics ... their growing line of products that address bone and soft tissue repair. ... Mr. Shane ... with our ability to provide innovative biologic products and to compete with ...
Cached Medicine Technology:Bayer HealthCare Announces Recipients of 2010 WFH International Hemophilia Nursing Fellowship 2Bayer HealthCare Announces Recipients of 2010 WFH International Hemophilia Nursing Fellowship 3Bayer HealthCare Announces Recipients of 2010 WFH International Hemophilia Nursing Fellowship 4Pioneer® Surgical Expands Product Specialists to Support Growing Biologics Business 2
(Date:7/25/2014)... Ticket Down announces that they ... Guinness International Champions Cup match between international soccer powerhouses ... on Sunday, July 27th. This well-known ticket ... SOCCER-2014 for added savings. , 2014 is turning out ... in North America. Countless international soccer teams have been ...
(Date:7/25/2014)... (GSA) the nation,s largest interdisciplinary organization ... chosen Heather M. Young, PhD, RN, FAAN, of ... recipient of the Doris Schwartz Gerontological Nursing Research ... Health Sciences Section, is given to a member ... sustained contribution to gerontological nursing research. , The ...
(Date:7/25/2014)... Island (PRWEB) July 25, 2014 Reproductive ... to announce that Dr. Kerri Luzzo, Lead Physician at ... Award" for her professional accomplishments in fertility care and ... , At the 10th Annual PBN Awards ceremony held ... Island, 40 of the most highly regarded, emerging leaders ...
(Date:7/25/2014)... The Little Gym of Houston will ... July 27 at Discovery Green in downtown Houston. The ... Pearland, Friendswood, Spring, The Woodlands, Sugarland-Missouri City, Kingwood, Bellaire ... “We’re thrilled to be attending and performing at the ... owns the Sugarland-Missouri City location. “We believe in the ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 AttorneyOne.com, a recognized ... latest information from the FDA on Ibuprofen and Oxcarbazepine ... that one lot of Ibuprofen and one lot of Oxcarbazepine ... due to mislabeled packaging. Oxcarbazepine is used for the treatment ... , The reason for the recall is that Lot ...
Breaking Medicine News(10 mins):Health News:Liverpool FC vs. Olympiacos FC Tickets Soldier Field: Ticket Down Slashes Ticket Prices for Guinness International Champions Cup in Chicago on Sunday, July 27th 2Health News:Young earns GSA's 2014 Doris Schwartz Gerontological Nursing Research Award 2Health News:Dr. Kerri Luzzo of the Reproductive Science Center of Providence Receives “40 Under Forty Award" for Outstanding Professional Accomplishments and Community Outreach 2Health News:The Little Gym of Houston to Attend Houston Family Magazine’s Family Fun Fest 2014 2Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2
... Texas, hospital go online with electronic health recordsNASHVILLE, ... (HMS) announced today that they and Cogdell Memorial ... Memorial selected HMS to supply a fully integrated ... the Snyder, Texas hospital closer to electronic health ...
... Jan. 7 The TV Teacher, LLC(TM) announces the,donation ... York City schools: Queens, Bronx, and Staten Island. , ... Beats(TM) was co-created,by Susan Ellis, a mother struggling to ... the alphabet. After an unsuccessful two years of,"traditional" ...
... Snow Jr., chairman and chief executive officer, Medco Health Solutions, ... the 27th Annual JPMorgan Healthcare Conference in San Francisco on ... Hotel, San Francisco, will begin at 8:30 a.m. PST (11:30 ... Richard J. Rubino, chief financial officer, and Robert S. Epstein, ...
... Mass., Jan. 7 Boston Scientific Corporation (NYSE: ... upcoming JP Morgan Health Care Conference in San Francisco.Jim ... on Wednesday, January 14th, beginning at approximately 12:00 p.m. ... President and Chief Financial Officer will join Mr. Tobin ...
... Trademark Office (USPTO) has registered Guru Program® as ... developed and honed by Tom Gable, of Gable ... USPTO language said the mark covered: consulting services ... legal and accounting services, health care, financial services, ...
... 7 Agito Networks, Inc.(TM), the,company delivering ... today,announced that Technology Marketing Corporation,s (TMC(R)) Unified,Communications ... Networks,RoamAnywhere(TM) Mobility Router(TM) as a recipient of ... Agito Networks, award-winning RoamAnywhere ...
Cached Medicine News:Health News:Cogdell Memorial Hospital Partners with Healthcare Management Systems 2Health News:Cogdell Memorial Hospital Partners with Healthcare Management Systems 3Health News:New York Schools Receive Program for Children with Autism 2Health News:Medco CEO to Present at the 27th Annual JPMorgan Healthcare Conference 2Health News:Guru Program Pioneered by Tom Gable Receives Official Registration from USPTO 2Health News:Guru Program Pioneered by Tom Gable Receives Official Registration from USPTO 3Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 2Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 3Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 4
... be used in facilities where space is ... ventilation and gas delivery technologies with an ... and the functionality of the Draeger Infinity ... yourself a workplace environment that is a ...
... superior ventilation., ,The Aestiva/5 offers exceptional ... approach to anesthesia therapy., ,The Aestiva/5 ... an intensive care ventilator, saving you the ... into the OR. Its flexible ergonomic design ...
With its integrated design and superior build quality each Prima SP is custom built to meet your requirements....
A non-adhering hydrogel sheet dressing for use on all partial and full thickness wounds (excluding 3rd degree burns.) Hydrogel sheet contains 96% water and 4% insoluble cross-linked polyethylene oxid...
Medicine Products: